Evaluation of result of Paribhdra & Amlaki kwath in Amlapitta(Hyperacidity) disease

Pharmacotherapeutic evaluation of Paribhadra Patra (Erythrina variegata Linn.) and Amlaki phala (Emblica officinalis Gaertn.) in the management of Amlapitta (Hyperacidity) - An exploratory study - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084669

Enrollment

Registered

2025-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K318- Other specified diseases of stomach and duodenum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Clinically and pathologically diagnosed patient , who are suffering from Amlapitta

Exclusion criteria

Exclusion criteria: 1. Subject should not suffering from Amlapitta more than 3 months 2. Age below 16 years and above 50 years 3. Subject reporting with complication like cardiac problem , emphysema, carcinoma etc. will be excluded 4. Pregnant woman and lactating mothers was excluded 5. Subject with gastric malignancy 6. Subject who recently undergo gastro-intestinal surgery

Design outcomes

Primary

Measure	Time frame
Changes in the objective parametersTimepoint: 1 month	—

Secondary

Measure	Time frame
Changes in the clinical sign and symptoms of AmlapittaTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Manoj Kumar Adlakha

Post Graduate Institute of Ayurveda DSRRAU Jodhpur

kalpana0210poonia@gmail.com8824705009

Outcome results